Specific NO-mediated PTMs are implicated in epilepsy; for example, NO is responsible for type 1 ryanodine receptor (RyR1) S-nitrosylation, inducing Ca2+ release from the endoplasmic reticulum through the Ca2 + release channel, and worsening the disease progression [71]. The gene discussed is RYR1; the disease is epilepsy.